Holen Sie sich die Stockscreener-App
452.77
0.02%
-0.09
Handel nachbörslich:
452.77
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt IDXX?
Forum
Prognose
Aktiensplit
Schlusskurs vom Vortag:
$452.86
Offen:
$454.41
24-Stunden-Volumen:
677.24K
Relative Volume:
1.11
Marktkapitalisierung:
$37.07B
Einnahmen:
$3.90B
Nettoeinkommen (Verlust:
$887.87M
KGV:
42.43
EPS:
10.67
Netto-Cashflow:
$808.08M
1W Leistung:
+1.85%
1M Leistung:
+5.95%
6M Leistung:
-8.53%
1J Leistung:
-18.39%
1-Tages-Spanne:
$452.46
$460.38
1-Wochen-Bereich:
$440.99
$460.38
52-Wochen-Spanne:
$398.50
$583.39
Idexx Laboratories Inc Stock (IDXX) Company Profile
Firmenname
Idexx Laboratories Inc
Sektor
Branche
Telefon
(207) 556-0300
Adresse
ONE IDEXX DRIVE, WESTBROOK, ME
Vergleichen Sie IDXX mit anderen Aktien
| Aktien | Preis | Marktkapitalisierung | Umsatz | Nettogewinn | Free Cashflow | ENV |
|---|---|---|---|---|---|---|
IDXX
Idexx Laboratories Inc
|
452.77 | 37.07B | 3.90B | 887.87M | 808.08M | 10.67 |
|
TMO
Thermo Fisher Scientific Inc
|
532.55 | 203.70B | 42.88B | 6.34B | 7.27B | 16.53 |
|
DHR
Danaher Corp
|
210.23 | 151.18B | 23.88B | 3.90B | 5.30B | 5.28 |
|
A
Agilent Technologies Inc
|
135.37 | 38.62B | 6.51B | 1.29B | 1.37B | 4.42 |
|
IQV
Iqvia Holdings Inc
|
191.04 | 33.64B | 15.41B | 1.37B | 2.11B | 7.50 |
Idexx Laboratories Inc Stock (IDXX) Upgrades & Downgrades
| Datum | Aktion | Analytiker | Ratingänderung |
|---|---|---|---|
| 2024-12-02 | Eingeleitet | Leerink Partners | Outperform |
| 2024-07-25 | Eingeleitet | BTIG Research | Buy |
| 2024-01-30 | Herabstufung | Piper Sandler | Overweight → Neutral |
| 2023-12-07 | Eingeleitet | Exane BNP Paribas | Outperform |
| 2023-12-04 | Hochstufung | Cleveland Research | Neutral → Buy |
| 2023-08-02 | Herabstufung | Atlantic Equities | Overweight → Neutral |
| 2022-07-25 | Herabstufung | Stifel | Buy → Hold |
| 2022-07-21 | Hochstufung | Goldman | Neutral → Buy |
| 2022-07-12 | Eingeleitet | Piper Sandler | Overweight |
| 2022-05-05 | Herabstufung | BofA Securities | Buy → Neutral |
| 2022-02-08 | Eingeleitet | Atlantic Equities | Overweight |
| 2021-11-18 | Eingeleitet | Morgan Stanley | Overweight |
| 2021-08-05 | Fortgesetzt | Credit Suisse | Outperform |
| 2021-07-12 | Herabstufung | Guggenheim | Buy → Neutral |
| 2021-02-17 | Eingeleitet | Barclays | Overweight |
| 2019-09-09 | Eingeleitet | Goldman | Neutral |
| 2019-05-23 | Eingeleitet | Guggenheim | Buy |
| 2018-11-02 | Bestätigt | BofA/Merrill | Buy |
| 2018-05-07 | Bestätigt | Stifel | Buy |
| 2018-01-16 | Eingeleitet | Piper Jaffray | Overweight |
| 2017-08-23 | Hochstufung | BofA/Merrill | Neutral → Buy |
| 2017-07-28 | Hochstufung | CL King | Neutral → Buy |
| 2017-02-03 | Herabstufung | Feltl & Co. | Hold → Sell |
| 2016-09-29 | Fortgesetzt | BofA/Merrill | Neutral |
| 2016-08-16 | Bestätigt | Stifel | Buy |
| 2016-08-03 | Hochstufung | Northcoast | Sell → Neutral |
| 2016-07-20 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-19 | Bestätigt | Canaccord Genuity | Buy |
| 2016-04-01 | Eingeleitet | CL King | Neutral |
| 2016-03-21 | Bestätigt | Stifel | Buy |
| 2016-02-04 | Eingeleitet | Credit Suisse | Outperform |
| 2015-10-29 | Bestätigt | Stifel | Buy |
| 2015-08-28 | Herabstufung | Raymond James | Outperform → Mkt Perform |
| 2015-08-13 | Bestätigt | Stifel | Buy |
| 2015-07-23 | Bestätigt | Canaccord Genuity | Buy |
Alle ansehen
Idexx Laboratories Inc Aktie (IDXX) Neueste Nachrichten
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Bought by Truist Financial Corp - MarketBeat
Allworth Financial LP Raises Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX LABORATORIES INC /DE SEC 10-K Report - TradingView
Flossbach Von Storch SE Raises Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Principal Financial Group Inc. Lowers Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Rhumbline Advisers Cuts Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Villere ST Denis J & Co. LLC Acquires 1,556 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Alberta Investment Management Corp Boosts Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
New York State Teachers Retirement System Trims Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Asset Management One Co. Ltd. Buys 3,057 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
TimesSquare Capital Management LLC Buys 46,857 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Chevy Chase Trust Holdings LLC Has $17.79 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
CIBC Asset Management Inc Has $10.90 Million Stock Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Should You Hold IDEXX Stock in Your Portfolio for Now? - Nasdaq
Waycross Partners LLC Takes Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by Congress Asset Management Co. - MarketBeat
IDEXX Laboratories' Quarterly Earnings Preview: What You Need to Know - MSN
Should You Invest in IDEXX Laboratories (IDXX)? - MSN
Blue Zone Wealth Advisors LLC Takes $3.96 Million Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Pittenger & Anderson Inc. Sells 16,496 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Sold by WD Rutherford LLC - MarketBeat
George Fennell Sells 9,986 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock - MarketBeat
Adell Harriman & Carpenter Inc. Invests $413,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Shares Acquired by Fiera Capital Corp - MarketBeat
Analysts Set IDEXX Laboratories, Inc. (NASDAQ:IDXX) Price Target at $533.75 - MarketBeat
CFC Planning Co LLC Purchases New Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Equitable Trust Co. Invests $676,000 in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Position Increased by Vontobel Holding Ltd. - MarketBeat
IDEXX Laboratories (IDXX) Fell Due to Weakening of Clinical Visits by Patients - MSN
Moloney Securities Asset Management LLC Purchases New Stake in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stake Raised by Marks Group Wealth Management Inc - MarketBeat
IDEXX Laboratories Announces Board Resignation - MSN
IDEXX Laboratories Announces Board Resignation By Investing.com - Investing.com South Africa
Idexx Laboratories Director Resigns, Board Size Reduced - TipRanks
M Anne Szostak Sells 3,000 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) Stock - MarketBeat
Thompson Investment Management Inc. Takes $310,000 Position in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Apollon Wealth Management LLC Sells 2,027 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Piper Sandler Increases IDEXX Laboratories (NASDAQ:IDXX) Price Target to $510.00 - MarketBeat
Sumitomo Mitsui Trust Group Inc. Has $82.05 Million Stock Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Fund Update: COMGEST GLOBAL INVESTORS S.A.S. added 145,203 shares of IDEXX LABS ($IDXX) to their portfolio - Nasdaq
IDEXX Laboratories to Present at Two Upcoming Institutional Investor Conferences - Business Wire
Entropy Technologies LP Has $2.27 Million Holdings in IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Why Idexx Labs Stock Rocketed Higher This Week - AOL
Options Movement At IDEXX Laboratories: Michael G Erickson Exercises Worth $597K - Benzinga
This Pet Healthcare Stock Is Booming – And It Still Looks Undervalued - Finimize
State of Alaska Department of Revenue Sells 1,986 Shares of IDEXX Laboratories, Inc. (NASDAQ:IDXX) - MarketBeat
Idexx Laboratories executive vice president sells $4.6 million in stock - MSN
Finanzdaten der Idexx Laboratories Inc-Aktie (IDXX)
Umsatz
Nettogewinn
Free Cashflow
ENV
1.04%
0.27%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):